$OPK
OPKO HEALTH, INC. Stock $opk

$opk Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000094480918000025 Filed on May 08, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$254.9M	$266.4M
YoY Change	-4.31%	-0.95%
Cost Of Revenue	$139.4M	$140.0M
YoY Change	-0.38%	1.72%
Gross Profit	$115.5M	$126.4M
YoY Change	-8.66%	-3.76%
Gross Profit Margin	45.3%	47.46%
Selling, General & Admin	$91.52M	$109.9M
YoY Change	-16.76%	-14.11%
% of Gross Profit	79.26%	86.97%
Research & Development	$32.89M	$26.56M
YoY Change	23.84%	-4.55%
% of Gross Profit	28.48%	21.01%
Depreciation & Amortization	$24.76M	$25.73M
YoY Change	-3.78%	15.91%
% of Gross Profit	21.44%	20.35%
Operating Expenses	$297.5M	$311.6M
YoY Change	-4.52%	3.96%
Operating Profit	-$42.61M	-$45.22M
YoY Change	-5.76%	64.31%
Interest Expense	-$800.0K	$2.900M
YoY Change	-127.59%	-190.63%
% of Operating Profit
Other Income/Expense, Net	$1.061M	$5.899M
YoY Change	-82.01%	-325.07%
Pretax Income	-$41.55M	-$39.32M
YoY Change	5.68%	30.45%
Income Tax	-$892.0K	-$6.944M
% Of Pretax Income
Net Earnings	-$43.11M	-$34.50M
YoY Change	24.96%	126.32%
Net Earnings / Revenue	-16.91%	-12.95%
Basic Earnings Per Share		-$0.06
Diluted Earnings Per Share	-$77.03K	-$0.06
COMMON SHARES
Basic Shares Outstanding	559.5M shares	558.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.90M	$131.1M
YoY Change	-23.8%	-25.09%
Cash & Equivalents	$99.94M	$131.1M
Short-Term Investments
Other Short-Term Assets	$4.370M	$3.848M
YoY Change	13.57%	1157.52%
Inventory	$49.82M	$47.49M
Prepaid Expenses
Receivables	$158.6M	$238.9M
Other Receivables	$25.40M	$28.90M
Total Short-Term Assets	$349.3M	$459.9M
YoY Change	-24.04%	1.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$148.7M	$126.3M
YoY Change	17.79%	-5.74%
Goodwill	$719.9M	$706.0M
YoY Change	1.97%	-5.49%
Intangibles
YoY Change
Long-Term Investments	$36.30M	$34.20M
YoY Change	6.14%	11.76%
Other Assets	$5.627M	$38.89M
YoY Change	-85.53%	760.08%
Total Long-Term Assets	$2.230B	$2.300B
YoY Change	-3.07%	-1.69%
TOTAL ASSETS
Total Short-Term Assets	$349.3M	$459.9M
Total Long-Term Assets	$2.230B	$2.300B
Total Assets	$2.579B	$2.760B
YoY Change	-6.56%	-1.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$64.23M	$74.56M
YoY Change	-13.85%	1.53%
Accrued Expenses	$217.1M	$178.9M
YoY Change	21.39%	-1.91%
Deferred Revenue	$61.38M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$40.10M	$11.53M
YoY Change	247.88%	0.64%
Total Short-Term Liabilities	$318.1M	$265.0M
YoY Change	20.05%	-0.85%
LONG-TERM LIABILITIES
Long-Term Debt	$1.432M	$1.462M
YoY Change	-2.05%	-38.21%
Other Long-Term Liabilities	$233.6M	$189.6M
YoY Change	23.23%	-31.27%
Total Long-Term Liabilities	$437.6M	$388.1M
YoY Change	12.73%	-26.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$318.1M	$265.0M
Total Long-Term Liabilities	$437.6M	$388.1M
Total Liabilities	$755.6M	$653.1M
YoY Change	15.7%	-17.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.075B	-$728.4M
YoY Change	47.61%	1.61%
Common Stock	$5.600M	$5.596M
YoY Change	0.07%	2.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.791M	$1.911M
YoY Change	-6.28%	0.0%
Treasury Stock Shares	549.9K shares	586.8K shares
Shareholders Equity	$1.823B	$2.107B
YoY Change
Total Liabilities & Shareholders Equity	$2.579B	$2.760B
YoY Change	-6.56%	-1.19%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$43.11M	-$34.50M
YoY Change	24.96%	126.32%
Depreciation, Depletion And Amortization	$24.76M	$25.73M
YoY Change	-3.78%	15.91%
Cash From Operating Activities	-$35.52M	-$33.92M
YoY Change	4.72%	268.44%
INVESTING ACTIVITIES
Capital Expenditures	-$6.000M	-$9.500M
YoY Change	-36.84%	-3.06%
Acquisitions
YoY Change
Other Investing Activities	$800.0K	$3.100M
YoY Change	-74.19%	-1133.33%
Cash From Investing Activities	-$5.146M	-$6.442M
YoY Change	-20.12%	-35.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$49.19M	$2.174M
YoY Change	2162.7%	4001.89%
NET CHANGE
Cash From Operating Activities	-$35.52M	-$33.92M
Cash From Investing Activities	-$5.146M	-$6.442M
Cash From Financing Activities	$49.19M	$2.174M
Net Change In Cash	$8.444M	-$38.19M
YoY Change	-122.11%	98.74%
FREE CASH FLOW
Cash From Operating Activities	-$35.52M	-$33.92M
Capital Expenditures	-$6.000M	-$9.500M
Free Cash Flow	-$29.52M	-$24.42M
YoY Change	20.89%	-4210.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000944809
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	559473838	shares
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	Opko Health, Inc.
CY2017Q4	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	12191000	USD
CY2018Q1	opk	Accrued Clinical Trials Current AccruedClinicalTrialsCurrent	14130000	USD
CY2018Q1	opk	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration If Estimated Future Sales Decrease Ten Percent BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationIfEstimatedFutureSalesDecreaseTenPercent	2500000	USD
CY2017Q4	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	4868000	USD
CY2018Q1	opk	Business Combination Deferred Acquisition Payments Netof Discount Current BusinessCombinationDeferredAcquisitionPaymentsNetofDiscountCurrent	4918000	USD
CY2017Q4	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	2000000000	USD
CY2018Q1	opk	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Goodwilland Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedGoodwillandIntangibleAssets	2000000000	USD
CY2017Q1	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	696000	USD
CY2018Q1	opk	Common Stock Warrants Net Exercised CommonStockWarrantsNetExercised	0	USD
CY2018Q1	opk	Contingent Membership Interest ContingentMembershipInterest	0.15
CY2017Q4	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	11	institution
CY2018Q1	opk	Debt Instruments Numberof Financial Institutions DebtInstrumentsNumberofFinancialInstitutions	11	institution
CY2018Q1	opk	Equity Method Investment Excluding Variable Interest Entity EquityMethodInvestmentExcludingVariableInterestEntity	21753000	USD
CY2018Q1	opk	Equity Method Investment Variable Interest Entity EquityMethodInvestmentVariableInterestEntity	545000	USD
CY2018Q1	opk	Equity Securities Fvni Realized Gain Loss EquitySecuritiesFVNIRealizedGainLoss	-1818000	USD
CY2018Q1	opk	Equity Securities Fvni Unrealized Gain Loss EquitySecuritiesFVNIUnrealizedGainLoss	-1931000	USD
CY2018Q1	opk	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1108000	USD
CY2018Q1	opk	Equity Security Fvni EquitySecurityFVNI	12879000	USD
CY2017Q1	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-32372000	USD
CY2018Q1	opk	Income Lossfrom Continuing Operations Before Investmentsin Investees Extraordinary Items Noncontrolling Interest Netof Tax IncomeLossfromContinuingOperationsBeforeInvestmentsinInvesteesExtraordinaryItemsNoncontrollingInterestNetofTax	-40658000	USD
CY2017Q1	opk	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	13849000	USD
CY2018Q1	opk	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	15358000	USD
CY2017Q1	opk	Increase Decrease In Equity Securities Fvni And Derivative Instruments IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments	4037000	USD
CY2018Q1	opk	Increase Decrease In Equity Securities Fvni And Derivative Instruments IncreaseDecreaseInEquitySecuritiesFVNIAndDerivativeInstruments	3101000	USD
CY2017Q1	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	-69000	USD
CY2018Q1	opk	Increase Decreasein Foreign Currency Measurement IncreaseDecreaseinForeignCurrencyMeasurement	-11000	USD
CY2017Q1	opk	Interest Expense Nonoperating InterestExpenseNonoperating	1429000	USD
CY2018Q1	opk	Interest Expense Nonoperating InterestExpenseNonoperating	2267000	USD
CY2017Q1	opk	Interest Income Nonoperating InterestIncomeNonoperating	249000	USD
CY2018Q1	opk	Interest Income Nonoperating InterestIncomeNonoperating	39000	USD
CY2018Q1	opk	Numberof Sales Employees NumberofSalesEmployees	400	employee
CY2017Q1	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	0	USD
CY2018Q1	opk	Other Comprehensive Income Loss Reclassification Adjustmentfrom Aoci For Adoption Of Accounting Standards Update Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIForAdoptionOfAccountingStandardsUpdateNetOfTax	4876000	USD
CY2018Q1	opk	Percentage Of Increase Decrease In Future Sales PercentageOfIncreaseDecreaseInFutureSales	-0.1
CY2017Q4	opk	Proceeds From Development And License Agreement Upfront Payment ProceedsFromDevelopmentAndLicenseAgreementUpfrontPayment	6000000	USD
CY2017Q1	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	15606000	USD
CY2017	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	15606000	USD
CY2018Q1	opk	Revenue From Transfer Of Intellectual Property RevenueFromTransferOfIntellectualProperty	15748000	USD
CY2017Q1	opk	Shares Surrendered In Lieu Of Cash Payment SharesSurrenderedInLieuOfCashPayment	84982	shares
CY2017Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	1106872	shares
CY2018Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercised	0	shares
CY2017Q1	opk	Stock Issued During Period Shares Stock Optionsand Warrants Exercised Netof Shares Surrenderedin Lieuof Cash Payment StockIssuedDuringPeriodSharesStockOptionsandWarrantsExercisedNetofSharesSurrenderedinLieuofCashPayment	1021890	shares
CY2018Q1	opk	Stock Optionand Warrant Investments StockOptionandWarrantInvestments	5004000	USD
CY2017Q4	opk	Taxes Recoverable Current TaxesRecoverableCurrent	18138000	USD
CY2018Q1	opk	Taxes Recoverable Current TaxesRecoverableCurrent	17359000	USD
CY2017Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	8798000	USD
CY2018Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	7980000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	74307000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	64229000	USD
CY2017Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	166962000	USD
CY2018Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	160169000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	165516000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	158642000	USD
CY2017Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	50377000	USD
CY2018Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	46708000	USD
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	4609000	USD
CY2018Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2592000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	230301000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	217133000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2355000	USD
CY2018Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2856000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-528000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	5600000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-539000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2889256000	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2895191000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9700000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5900000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1400000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1446000	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1527000	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1500000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	56000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	43000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17929000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17900000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17300000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17271000	USD
CY2017Q4	us-gaap	Assets Assets	2589956000	USD
CY2018Q1	us-gaap	Assets Assets	2578894000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	348861000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	349346000	USD
CY2017Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2371000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1759000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	41400000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	43100000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	11750000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	5254000	USD
CY2017Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	29603000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	37858000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3399000	USD
CY2018Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3366000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	7786000	USD
CY2018Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	7342000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	168733000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	131052000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91499000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99943000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-37681000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	8444000	USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	560023745	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	560023745	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	5600000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-32447000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-43125000	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	140400000	USD
CY2018Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	125000000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	61388000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	61378000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	78990000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	63642000	USD
CY2017Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	29160000	USD
CY2018Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	55199000	USD
CY2017Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	14830000	USD
CY2018Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	14648000	USD
CY2017Q1	us-gaap	Cost Of Services CostOfServices	139966000	USD
CY2018Q1	us-gaap	Cost Of Services CostOfServices	139441000	USD
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9236000	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2709000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	148729000	USD
CY2018Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	148732000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	7800000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	7500000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25730000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24757000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	506000	USD
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-81000	USD
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	13600000	USD
CY2018Q1	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	0	USD
CY2017Q1	us-gaap	Embedded Derivative Gain On Embedded Derivative EmbeddedDerivativeGainOnEmbeddedDerivative	3200000	USD
CY2018Q1	us-gaap	Equity Method Investment Quoted Market Value EquityMethodInvestmentQuotedMarketValue	43800000	USD
CY2018Q1	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	382200000	USD
CY2018Q1	us-gaap	Equity Method Investment Summarized Financial Information Liabilities EquityMethodInvestmentSummarizedFinancialInformationLiabilities	142700000	USD
CY2018Q1	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-20800000	USD
CY2018Q1	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	23590000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	198935000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	216656000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	683835000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	667637000	USD
CY2017Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	4037000	USD
CY2018Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1396000	USD
CY2017Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2131000	USD
CY2018Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2456000	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-113000	USD
CY2017Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2997000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	717099000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	719891000	USD
CY2018Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	2792000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-39316000	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	261000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-41550000	USD
CY2017Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2131000	USD
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2456000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6944000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-892000	USD
CY2017Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	848000	USD
CY2018Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2292000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	19539000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-10206000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17771000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6757000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-16024000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-8829000	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-13849000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	50000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-204000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	235000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	131000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4692000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5445000	USD
CY2017Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	647347000	USD
CY2018Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	646386000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	550000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	641000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	21012000	USD
CY2018Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	22137000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	49333000	USD
CY2018Q1	us-gaap	Inventory Net InventoryNet	49815000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	7467000	USD
CY2018Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	6892000	USD
CY2017Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	6565000	USD
CY2018Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	5857000	USD
CY2017Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5873000	USD
CY2018Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	4505000	USD
CY2017Q1	us-gaap	Inventory Write Down InventoryWriteDown	4600000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	734378000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	755630000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2589956000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2578894000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	316534000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	318077000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	417844000	USD
CY2018Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	437553000	USD
CY2017Q4	us-gaap	Line Of Credit LineOfCredit	114664000	USD
CY2018Q1	us-gaap	Line Of Credit LineOfCredit	110943000	USD
CY2018Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	197411000	USD
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	11926000	USD
CY2018Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	6971000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1567000	USD
CY2018Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1432000	USD
CY2017Q4	us-gaap	Long Term Investments LongTermInvestments	40642000	USD
CY2018Q1	us-gaap	Long Term Investments LongTermInvestments	41289000	USD
CY2017Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	104152000	USD
CY2018Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	105091000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2174000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	49191000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6442000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5146000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33919000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35520000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5899000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1061000	USD
CY2018Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	311597000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	297525000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-45215000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-42611000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	79364000	USD
CY2018Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	75931000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3838000	USD
CY2018Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4370000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5615000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5627000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2592000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4865000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-536000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2017Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	21546000	USD
CY2018Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	22138000	USD
CY2017Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	17857000	USD
CY2018Q1	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	18257000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	239955000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	233622000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3042000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1893000	USD
CY2017Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	640000	USD
CY2018Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	843000	USD
CY2017Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2018Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1000000	USD
CY2017Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	9537000	USD
CY2018Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5973000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42513000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	40946000	USD
CY2017Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3532000	USD
CY2018Q1	us-gaap	Prepaid Insurance PrepaidInsurance	2179000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	55000000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1866000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2017Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	7825000	USD
CY2018Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	6611000	USD
CY2017Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	0	USD
CY2018Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	1286000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3095000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	541000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-34503000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-34503000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-43114000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	146557000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	148718000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	900000	USD
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000	USD
CY2018Q1	us-gaap	Purchase Obligation PurchaseObligation	82500000	USD
CY2017Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	7517000	USD
CY2018Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	12420000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26557000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26557000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32887000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1036959000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1075197000	USD
CY2017Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	228545000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	211315000	USD
	us-gaap	Revenue Recognition Milestone Method Revenue Recognized RevenueRecognitionMilestoneMethodRevenueRecognized	0	USD
CY2017Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	22231000	USD
CY2018Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	27851000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	266382000	USD
CY2018Q1	us-gaap	Sales Revenue Net SalesRevenueNet	254914000	USD
CY2017Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	228545000	USD
CY2017	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	228545000	USD
CY2018Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	211315000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	109944000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	109944000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	91519000	USD
CY2017Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	0	USD
CY2018Q1	us-gaap	Senior Notes Current SeniorNotesCurrent	29744000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9693000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5936000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1855578000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1823264000	USD
CY2017Q4	us-gaap	Supplies Supplies	8207000	USD
CY2018Q1	us-gaap	Supplies Supplies	9058000	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	549907	shares
CY2018Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	549907	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1791000	USD
CY2018Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1791000	USD
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	558434153	shares
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	559473838	shares
CY2018Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font><font style="font-family:inherit;font-size:10pt;">. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000944809-18-000025-index-headers.html	Edgar Link	pending
0000944809-18-000025-index.html	Edgar Link	pending
0000944809-18-000025.txt	Edgar Link	pending
0000944809-18-000025-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
opk-20180331.xml	Edgar Link	completed
opk-20180331.xsd	Edgar Link	pending
opk-20180331_cal.xml	Edgar Link	unprocessable
opk-20180331_def.xml	Edgar Link	unprocessable
opk-20180331_lab.xml	Edgar Link	unprocessable
opk-20180331_pre.xml	Edgar Link	unprocessable
opk-3312018x10q.htm	Edgar Link	pending
opk-3312018xex311.htm	Edgar Link	pending
opk-3312018xex312.htm	Edgar Link	pending
opk-3312018xex321.htm	Edgar Link	pending
opk-3312018xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPK
OPKO HEALTH, INC. Stock $opk

2018 Q1 Form 10-Q Financial Statement

#000094480918000025 Filed on May 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK OPKO HEALTH, INC. Stock $opk

2018 Q1 Form 10-Q Financial Statement

#000094480918000025 Filed on May 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPK
OPKO HEALTH, INC. Stock $opk